What we do
TBnet is a European grass-root consortium consisting of health care professionals and scientists, aimed at promoting quality of care for tuberculosis patients by addressing health-inequalities, providing expert guidance in areas where clinical evidence is missing, defining research priorities, conducting multicenter clinical studies, and training early career European clinicians and scientists.
Frank van Leth
is an Associate Professor of Global Health at the Amsterdam UMC location AMC, and an academic staff member at the Amsterdam Institute for Global Health and Development. His research is on infectious disease epidemiology with the focus on methodological approaches that inform Public Health interventions. He currently holds the TBnet chair in the Steering Committee.
is a Clinical Microbiologist, that has been working in the last years in developing new methods for diagnosing latent and active TB. Jose is a member of the Steering Committee is in charge of the Microbiology and Drug Resistant issues.
is an infectious diseases physician with experience in managing HIV and TB infections in resource limited settings. In 2018, she obtained her PhD on pharmacokinetics of TB drugs. She is currently working as a medical monitor for the TB-PRACTECAL clinical trial with MSF-UK, and she collaborates as a clinical adviser to the EndTB clinical trial with MSF-France. Ilaria is a member of the Steering Committee in charge of Clinical Tuberculosis area.
is the Medical Director of the Research Center Borstel, Germany. He is a physician scientist with a strong interest in European healthcare systems and personalized medicine for patients with drug-resistant tuberculosis.
is a microbiologist/ molecular biologist; she is interested in metabolites as biomarkers in diagnostics of infectious diseases and metabolomics for understanding host pathogen interactions / antibacterial effect of drugs. She currently is the Vice Chair of the TBnet.
is a postdoctoral researcher at Research Center Borstel focusing on TB diagnostics, novel biomarkers of disease and cure and treatment monitoring tools. In 2014 she obtained her PhD in genetics of Mycobacterium tuberculosis. As a member of the TBnet Steering Committee, she is responsible for diagnostics.
is a clinician epidemiologist, working as a doctor and researcher in the Department for Infectious Diseases at the University of Freiburg, Germany. Within TBNet she is responsible for Epidemiology.
Jakko van Ingen
Jakko van Ingen, MD, PhD is a consultant clinical microbiologist, head of the mycobacteriology reference laboratory at Radboud University Medical Center in Nijmegen, the Netherlands and author of 150 papers on mycobacterial disease.
has been a member of TBnet since its foundation in 2006. Since then he has been responsible for the budget - an easy task for him as he is a tax consultant and chartered accountant in everyday life and is particularly active in the fields of healthcare and research.
is an immunologist and head of the department of transplant and infection immunology at Saarland University in Homburg, Germany. Her research focuses on the development of diagnostic tests for latent and active infection with M. tuberculosis. Within TBnet, she is responsible for translational research.
is an Infectious Diseases physician and researcher in Epidemiology at Médecins Sans Frontières (Doctors Without Borders) and at the National Reference Center for Mycobacteria in Paris, France. His research focus is the development of new treatment approaches for drug-resistant tuberculosis. He currently is the Vice Chair of the TBnet.